Published in J Med Microbiol on March 01, 1986
Production and characterization of monoclonal antibodies against serotype strains of Pseudomonas aeruginosa. Infect Immun (1987) 2.43
Occurrence of a common lipopolysaccharide antigen in standard and clinical strains of Pseudomonas aeruginosa. J Clin Microbiol (1989) 2.07
Pseudomonas aeruginosa population structure revisited. PLoS One (2009) 1.68
Conversion of Pseudomonas aeruginosa to the phenotype characteristic of strains from patients with cystic fibrosis. J Clin Microbiol (1990) 1.60
Interaction of gentamicin with the A band and B band lipopolysaccharides of Pseudomonas aeruginosa and its possible lethal effect. Antimicrob Agents Chemother (1993) 1.57
Cloning and surface expression of Pseudomonas aeruginosa O antigen in Escherichia coli. Proc Natl Acad Sci U S A (1992) 1.43
Antibody responses to lipid A, core, and O sugars of the Pseudomonas aeruginosa lipopolysaccharide in chronically infected cystic fibrosis patients. J Clin Microbiol (1992) 0.90
Comparison of polyclonal rabbit antisera with monoclonal antibodies for serological typing of Pseudomonas aeruginosa. J Clin Microbiol (1988) 0.78
Antibody response of fibrocystic patients to homologous 0-typable and 0-defective isolates of Pseudomonas aeruginosa. J Clin Pathol (1990) 0.77
Isolation of Escherichia coli, Pseudomonas aeruginosa, and Klebsiella from food in hospitals, canteens, and schools. Lancet (1971) 3.70
Properties of strains of Escherichia coli isolated from a variety of sources. J Med Microbiol (1975) 3.54
Comparison of outbreak and nonoutbreak Acinetobacter baumannii strains by genotypic and phenotypic methods. J Clin Microbiol (1996) 3.52
Imported melioidosis in England and Wales. Lancet (1999) 3.42
Use of sequence-based typing and multiplex PCR to identify clonal lineages of outbreak strains of Acinetobacter baumannii. Clin Microbiol Infect (2007) 3.00
Staphylococcus aureus isolates carrying Panton-Valentine leucocidin genes in England and Wales: frequency, characterization, and association with clinical disease. J Clin Microbiol (2005) 2.95
Aerosol carbenicillin and gentamicin treatment of Pseudomonas aeruginosa infection in patients with cystic fibrosis. Lancet (1981) 2.87
Food and medicaments as possible sources of hospital strains of Pseudomonas aeruginosa. Lancet (1969) 2.79
Hospital food as a possible source of Escherichia coli in patients. Lancet (1970) 2.62
The relationship between the O-antigenic lipopolysaccharides and serological specificity in strains of Pseudomonas aeruginosa of different O-serotypes. J Gen Microbiol (1973) 2.61
Release factor RF3 in E.coli accelerates the dissociation of release factors RF1 and RF2 from the ribosome in a GTP-dependent manner. EMBO J (1997) 2.61
Epidemiological typing of klebsiellae with extended-spectrum beta-lactamases from European intensive care units. J Antimicrob Chemother (1998) 2.51
Changing faecal population of Escherichia coli in hospital medical patients. Br Med J (1969) 2.48
Discriminatory power of three DNA-based typing techniques for Pseudomonas aeruginosa. J Clin Microbiol (1995) 2.43
Role of lipopolysaccharide in virulence of Pseudomonas aeruginosa. Infect Immun (1984) 2.39
Correlation of typing methods for Acinetobacter isolates from hospital outbreaks. J Clin Microbiol (1993) 2.38
Animal sources of common serotypes of Escherichia coli in the food of hospital patients. Possible significance in urinary-tract infections. Lancet (1970) 2.29
The fate of ingested Pseudomonas aeruginosa in normal persons. J Med Microbiol (1969) 2.28
Workshop on methicillin-resistant Staphylococcus aureus held at the headquarters of the Public Health Laboratory Service on 8 January 1985. J Hosp Infect (1985) 2.27
Pilus-dependence of four Pseudomonas aeruginosa bacteriophages with non-contractile tails. J Gen Virol (1974) 2.23
Properties of strains of Escherichia coli isolated from the faeces of patients with ulcerative colitis, patients with acute diarrhoea and normal persons. J Pathol Bacteriol (1968) 2.15
Epidemic of Pseudomonas cepacia in an adult cystic fibrosis unit: evidence of person-to-person transmission. J Clin Microbiol (1993) 2.12
Biochemical characteristics of clinical and environmental isolates of Burkholderia pseudomallei. J Med Microbiol (1996) 2.11
Comparison of ribotyping with conventional methods for the type identification of Enterobacter cloacae. J Clin Microbiol (1991) 2.06
Fate of ingested Escherichia coli in normal persons. J Med Microbiol (1972) 2.02
Management of pneumothorax in adults with cystic fibrosis. Thorax (1982) 1.99
Evaluation of electrophoretic methods for typing methicillin-resistant Staphylococcus aureus. J Med Microbiol (1988) 1.98
Physical map of the linear chromosome of the bacterium Borrelia burgdorferi 212, a causative agent of Lyme disease, and localization of rRNA genes. J Bacteriol (1992) 1.96
Auxotrophic variants of Pseudomonas aeruginosa are selected from prototrophic wild-type strains in respiratory infections in patients with cystic fibrosis. J Clin Microbiol (1995) 1.87
Frequency of faecal Klebsiella aerogenes in patients with ankylosing spondylitis and controls with respect to individual features of the disease. Ann Rheum Dis (1980) 1.85
A quantitative comparison of the faecal flora of patients with ulcerative colitis and that of normal persons. J Pathol Bacteriol (1967) 1.84
An investigation into the incidence and sources of klebsiella infections in hospital patients. J Hyg (Lond) (1979) 1.83
A prevalent, multiresistant clone of Acinetobacter baumannii in Southeast England. J Hosp Infect (2004) 1.74
A sequential study of the relationship between faecal Klebsiella aerogenes and the common clinical manifestations of ankylosing spondylitis. Ann Rheum Dis (1982) 1.73
The development and assessment of a bacteriocin typing method for Klebsiella. J Hyg (Lond) (1979) 1.71
2-Heptyl-4-hydroxyquinoline N-oxide, an antistaphylococcal agent produced by Pseudomonas aeruginosa. J Antimicrob Chemother (1992) 1.71
Latex agglutination test for identification of Pseudomonas pseudomallei. J Clin Pathol (1993) 1.67
Fast recycling of Escherichia coli ribosomes requires both ribosome recycling factor (RRF) and release factor RF3. EMBO J (1997) 1.65
Serious infection caused by group C streptococci. J Clin Pathol (1980) 1.56
The high amino-acid content of sputum from cystic fibrosis patients promotes growth of auxotrophic Pseudomonas aeruginosa. J Med Microbiol (1996) 1.52
Airborne infection in a fully air-conditioned hospital. IV. Airborne dispersal of Staphylococcus aureus and its nasal acquisition by patients. J Hyg (Lond) (1975) 1.50
Burkholderia pseudomallei and Indian plague-like illness. Lancet (1995) 1.44
Isolation of intestinal spirochaetes from homosexuals. J Clin Pathol (1981) 1.43
Escherichia coli serotype distribution in man and animals. J Hyg (Lond) (1974) 1.43
Mapping of genes on the linear chromosome of the bacterium Borrelia burgdorferi: possible locations for its origin of replication. FEMS Microbiol Lett (1992) 1.42
Faecal carriage of Pseudomonas aeruginosa by newborn babies. Lancet (1970) 1.41
Ribosome release factor RF4 and termination factor RF3 are involved in dissociation of peptidyl-tRNA from the ribosome. EMBO J (1998) 1.41
Micro-organisms isolated from skin under wedding rings worn by hospital staff. Br Med J (Clin Res Ed) (1985) 1.41
Ribotype differences between clinical and environmental isolates of Burkholderia pseudomallei. J Med Microbiol (1997) 1.38
Relationships among Pseudomonas pseudomallei isolates from patients with recurrent melioidosis. J Clin Microbiol (1993) 1.37
Increased sputum amino acid concentrations and auxotrophy of Pseudomonas aeruginosa in severe cystic fibrosis lung disease. Thorax (2000) 1.37
Adult cystic fibrosis: association of acute pulmonary exacerbations and increasing severity of lung disease with auxotrophic mutants of Pseudomonas aeruginosa. Thorax (1993) 1.37
Increased incidence of faecal coliforms with in vitro adhesive and invasive properties in patients with ulcerative colitis. Gut (1980) 1.37
A comparison of flagellar typing and phage typing as means of subdividing the O groups of Pseudomonas aeruginosa. J Med Microbiol (1981) 1.34
Escherichia coli in retail processed food. J Hyg (Lond) (1985) 1.34
Klebsiella pneumoniae infections in Greek hospitals. Dissemination of plasmids encoding an SHV-5 type beta-lactamase. J Hosp Infect (1995) 1.31
A direct estimation of the context effect on the efficiency of termination. J Mol Biol (1998) 1.31
The specificity of agglutination reactions of Pseudomonas aeruginosa with O antisera. J Med Microbiol (1978) 1.29
A double-blind trial of a single intravenous dose of metronidazole as prophylaxis against wound infection following appendicectomy. Br J Surg (1979) 1.27
The cost of infection in surgical patients: a case-control study. J Hosp Infect (1993) 1.26
The epidemiological type identification of Serratia marcescens from outbreaks of infection in hospitals. J Hyg (Lond) (1980) 1.24
Distribution of genes encoding putative transmissibility factors among epidemic and nonepidemic strains of Burkholderia cepacia from cystic fibrosis patients in the United Kingdom. J Clin Microbiol (2000) 1.24
Home-use nebulizers: a potential primary source of Burkholderia cepacia and other colistin-resistant, gram-negative bacteria in patients with cystic fibrosis. J Clin Microbiol (1996) 1.22
Preparation of agglutinating antisera specific for the flagellar antigens of Pseudomonas aeruginosa. J Med Microbiol (1981) 1.22
Auxotrophy of Pseudomonas aeruginosa in cystic fibrosis. FEMS Microbiol Lett (1992) 1.21
Pneumococci causing invasive disease in Britain 1982-1990. J Med Microbiol (1998) 1.19
New bacteriophage typing scheme for subdivision of the frequent capsular serotypes of Klebsiella spp. J Clin Microbiol (1987) 1.17
Secretory IgA: immune defence pattern in ankylosing spondylitis and klebsiella. Ann Rheum Dis (1981) 1.16
Acquisition of Klebsiella aerogenes by neonates. J Med Microbiol (1979) 1.16
Properties of strains of Escherichia coli carried in different phases of ulcerative colitis. Gut (1974) 1.15
The effect of diet on intestinal Escherichia coli. J Hyg (Lond) (1977) 1.15
Cross infection of cystic fibrosis patients with Pseudomonas aeruginosa. Thorax (2002) 1.14
Miscarriage rates following in-vitro fertilization are increased in women with polycystic ovaries and reduced by pituitary desensitization with buserelin. Hum Reprod (1993) 1.14
Auxotrophy of Burkholderia (Pseudomonas) cepacia from cystic fibrosis patients. J Clin Microbiol (1995) 1.14
Isolation of Acinetobacter spp. including A. baumannii from vegetables: implications for hospital-acquired infections. J Hosp Infect (1999) 1.14
Extrachromosomal elements of spirochetes. Res Microbiol (1993) 1.13
Antibiotic sensitivity of Escherichia coli isolated from animals, food, hospital patients, and normal people. Lancet (1971) 1.12
PSE-4 beta lactamase: a serotype-specific enzyme in Pseudomonas aeruginosa. J Med Microbiol (1985) 1.12
Isolation and characterization of a plasmid from Treponema denticola. FEMS Microbiol Lett (1991) 1.12
Biology of Pseudomonas aeruginosa in relation to pulmonary infection in cystic fibrosis. J R Soc Med (1986) 1.12
O serotyping scheme for Enterobacter cloacae. J Clin Microbiol (1983) 1.12
An outbreak of melioidosis in imported primates in Britain. Vet Rec (1992) 1.11
State of the art: typing Pseudomonas aeruginosa. J Hosp Infect (1980) 1.11
The production of antisera to the Klebsiella capsular antigens. J Appl Bacteriol (1979) 1.09
Stability of strain genotypes of Burkholderia pseudomallei from patients with single and recurrent episodes of melioidosis. Trop Med Int Health (1998) 1.08
The isolation of Escherichia coli from a poultry packing station and an abattoir. J Hyg (Lond) (1974) 1.08
Adhesive properties of Escherichia coli from urinary-tract infections. J Med Microbiol (1980) 1.07
Current problems with methicillin-resistant Staphylococcus aureus. J Hosp Infect (1988) 1.07
The production of colonic auto-antibodies in rabbits by immunisation with Escherichia coli. J Pathol Bacteriol (1968) 1.05
Latex agglutination for rapid detection of Pseudomonas pseudomallei antigen in urine of patients with melioidosis. J Clin Pathol (1995) 1.05
Pseudomonas cepacia pulmonary infection in adults with cystic fibrosis: is nosocomial acquisition occurring? J Hosp Infect (1992) 1.04
An evaluation of surveillance methods for detecting infections in hospital inpatients. J Hosp Infect (1993) 1.04
Dissociation of surface properties and "intrinsic" resistance to beta lactams in Pseudomonas aeruginosa. J Med Microbiol (1986) 1.04
Effect of klebsiella capsular antisera on lymphocytes from patients with ankylosing spondylitis. J Med Microbiol (1981) 1.03
Simultaneous culture of saliva and jejunal aspirate in the investigation of small bowel bacterial overgrowth. Gut (1982) 1.03
A comparison of typing methods for Serratia marcescens. J Hyg (Lond) (1977) 1.02
Ticarcillin compared with carbenicillin in the treatment of exacerbations of bronchopulmonary infection in cystic fibrosis. Br J Dis Chest (1983) 1.02
Epidemiologically related and unrelated strains of Pseudomonas aeruginosa serotype O12 cannot be distinguished by phenotypic and genotypic typing. J Hosp Infect (1997) 1.02
Adult cystic fibrosis: postprandial response of gut regulatory peptides. Gastroenterology (1983) 1.01
A method for the detection of gelatinase production by bacteria. J Appl Bacteriol (1970) 1.00